Education
About Us
Working with TipRanks
Follow Us
Izotropic Corp (TSE:IZO)
:IZO
IZO Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.04 - C$0.47
Previous CloseN/A
Volume236.24K
Average Volume (3M)51.69K
Market Cap
C$23.92M
Enterprise ValueC$14.21M
Total Cash (Recent Filing)C$220.78K
Total Debt (Recent Filing)C$2.03M
Price to Earnings (P/E)―
Beta-0.81
Next Earnings
Dec 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding64,653,680
10 Day Avg. Volume31,774
30 Day Avg. Volume51,689
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Izotropic News
IZO FAQ
What was Izotropic Corp’s price range in the past 12 months?
Izotropic Corp lowest stock price was C$0.04 and its highest was C$0.47 in the past 12 months.
What is Izotropic Corp’s market cap?
Izotropic Corp’s market cap is C$23.92M.
When is Izotropic Corp’s upcoming earnings report date?
Izotropic Corp’s upcoming earnings report date is Dec 18, 2025 which is in 70 days.
How were Izotropic Corp’s earnings last quarter?
Currently, no data Available
Is Izotropic Corp overvalued?
According to Wall Street analysts Izotropic Corp’s price is currently Overvalued.
Does Izotropic Corp pay dividends?
Izotropic Corp does not currently pay dividends.
What is Izotropic Corp’s EPS estimate?
Izotropic Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Izotropic Corp have?
Izotropic Corp has 64,653,680 shares outstanding.
What happened to Izotropic Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Izotropic Corp?
Currently, no hedge funds are holding shares in TSE:IZO
Company Description
Izotropic Corp
Izotropic Corporation, a MedTech company, commercializes diagnostic products for breast cancer. It develops and commercializes breast CT Imaging system; and 3D CT breast imaging platform for the earlier detection and diagnosis of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.
Technical Analysis
BioMark Diagnostics
―
―
Telo Genomics Corp
―
StageZero Life Sciences Ltd
―
Sona Nanotech Inc
―
Options Prices
Currently, No data available
---